Investigator Agreement Template for Singapore

An Investigator Agreement is a fundamental legal contract that governs the relationship between research sponsors, institutions, and principal investigators conducting clinical trials or biomedical research in Singapore. This agreement establishes clear responsibilities, ensures regulatory compliance, and protects the interests of all parties involved in research activities.

When do you need this document?

You need an Investigator Agreement whenever you're conducting clinical trials for pharmaceutical products, medical devices, or biomedical research involving human subjects in Singapore. This includes multi-center studies where different investigators work across various institutions, contract research arrangements between sponsors and clinical research organizations, and academic research collaborations involving external funding. The agreement is particularly crucial when research involves personal data collection, international sponsors working with local investigators, or studies requiring compliance with Good Clinical Practice guidelines.

Key legal considerations

The agreement must clearly define each party's roles and responsibilities, including the investigator's obligation to conduct research according to approved protocols and regulatory standards. Critical clauses should address compliance with Singapore's clinical trial regulations, data protection requirements under the Personal Data Protection Act, and intellectual property ownership. You must include provisions for safety monitoring, adverse event reporting, and study termination procedures. The contract should specify indemnification terms, insurance requirements, and compensation structures. Publication rights, confidentiality obligations, and record retention requirements are equally important to prevent disputes and ensure regulatory compliance.

Legal requirements in Singapore

Singapore's regulatory framework requires strict adherence to the Medicines Act (Chapter 176) for clinical trials involving therapeutic products, and the Human Biomedical Research Act 2015 for all biomedical research involving human subjects. Investigators must obtain approval from the Health Sciences Authority (HSA) for clinical trials and institutional review board approval for research protocols. The agreement must ensure compliance with the Personal Data Protection Act 2012 when handling participant data, including provisions for data collection, storage, and transfer. Additionally, investigators must follow the Singapore Medical Council's Ethical Code and Guidelines, and international standards such as Good Clinical Practice guidelines. The contract should address regulatory inspection requirements, documentation standards, and reporting obligations to relevant authorities.